Delivery Order SPE2DR25D2100-SPE2DR26FA0CH
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,243.20 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30 units) on July 24, 2025, with completion targeted for July 25, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $3,668.77 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30 units) on August 7, 2025, with an ultimate completion date of August 8, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of AmerisourceBergen's substantial role as a pharmaceutical supplier to federal medical procurement needs. The contract is being performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,396.57 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% Eye Drops (30 units) on July 21, 2025, with completion scheduled for July 22, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,361.54 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30-count units) on September 9, 2025, with an ultimate completion date of September 10, 2025. This is a firm fixed price contract with no set-aside designation, performed at the contractor's location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,105.42 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (70 units) on September 15, 2025, with completion scheduled for September 16, 2025. This firm fixed-price delivery order represents a non-competitive award under an existing contract vehicle and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,044.04 to AmerisourceBergen Drug Corp for the supply of Refresh Plus 0.5% eye drops in 30-unit quantities. This is a firm fixed price, non-competitive delivery order that was awarded on October 16, 2025, with an ultimate completion date of October 17, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,002.94 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (50-count unit dose) on September 12, 2025, with a completion date of September 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger prime contract vehicle with DLA. The work will be performed at the contractor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30 count) valued at $4,034.24 on April 24, 2025, with completion scheduled for April 25, 2025. This competitively awarded, non-set-aside contract was issued on a firm fixed-price basis and represents a child delivery order under a larger contract vehicle. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical...
- The Defense Logistics Agency awarded a $20,829.15 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for Refresh Plus 0.5% eye drops (30-count units). This is a firm fixed-price, competitively awarded contract with a completion date of September 15, 2025, and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle. The contract specifies performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (50 unit dose supplies) valued at $1,087.55 under a firm fixed-price contract. This non-set-aside delivery order was awarded on April 30, 2025, with an ultimate completion date of May 1, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- SPE2DR25D2100Indefinite Delivery Contract
- SPE2DR25D2100-SPE2DR26FA0CHDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,004.38 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30 units) on November 14, 2025, with an ultimate completion date of November 17, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is part of AmerisourceBergen Drug Corp's comprehensive pharmaceutical supply portfolio supporting federal military and healthcare systems. As a major pharmaceutical distributor and critical vendor for DLA Medical Supply Chain operations, AmerisourceBergen fulfills diverse medical procurement needs ranging from specialty medications and vaccines to medical devices and supplies. The SPE2DX prime IDC serves as a global pharmaceutical support vehicle enabling the company to supply military healthcare programs worldwide, with customers including the Defense Health Agency and U.S. Coast Guard, while DLA Troop Support plans to establish additional Pharmaceutical Prime Vendor Global Program Generation V contracts across multiple regions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 11/14/25 |